NCT00064311
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +103 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
Clinical trial condition
Testicular Germ Cell Tumor
Explore clinical trials studying Testicular Germ Cell Tumor. Study availability and eligibility vary by location and protocol.
59 public trials
3 recruiting studies
Testicular Germ Cell Tumor trial results
NCT00003887
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +123 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00002508
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +20 more
- Locations
-
- Temple University Cancer Center Philadelphia, Pennsylvania, United States
NCT00082654
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +108 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00109993
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
- Locations
-
- Mt. Sinai Medical Center New York, United States
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Oregon Health Sciences University Portland, Oregon, United States
NCT00410657
- Conditions
- Aberrant Motor Behavior in Dementia, Adnexal Diseases, Aggression, +109 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00010283
- Conditions
- Adnexal Diseases, Amyloidosis, Blast Crisis, +137 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00004157
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +94 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
Active, Not Recruiting
A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
NCT05238883
- Conditions
- Adenocarcinoma, Adenoma, Bronchial Neoplasms, +57 more
- Locations
-
- Mayo Clinic Scottsdale, Arizona, United States
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
- Mayo Clinic Jacksonville, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States